These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3478050)

  • 1. In vitro antibacterial activity of enoxacin, a new pyridonecarboxylic acid.
    Fabio U; Bondi M; Galletti F; Manicardi G; Messi P; Neglia R; Casolari C
    Boll Ist Sieroter Milan; 1987; 66(2):110-5. PubMed ID: 3478050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of CI-934--a new quinolone derivative.
    Finch R; Martin J; Pilkington R
    Chemioterapia; 1986 Dec; 5(6):368-74. PubMed ID: 3467873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E; Schito GC; Nicoletti G; Speciale A
    Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro antibacterial activity of two brands of antibiotics against clinical isolates of some bacterial genera.
    Odelola HA; Jaiyebo O; Anukam PA; Akanni AO
    Afr J Med Med Sci; 1989 Dec; 18(4):307-10. PubMed ID: 2558563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli.
    Miyake Y; Mitsui K; Suginaka H
    J Antimicrob Chemother; 1986 Mar; 17(3):327-32. PubMed ID: 3084441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents.
    Vanhoof R; Hubrechts JM; Roebben E; Claeys M; Nyssen HJ
    J Antimicrob Chemother; 1986 Mar; 17(3):297-302. PubMed ID: 3457785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimicrobial activities of ribostamycin, gentamicin, ampicillin and lincomycin in vitro and in vivo.
    Inouye S; Watanabe T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):465-76. PubMed ID: 2632215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of piperacillin and other microbials on 491 bacterial isolates.
    Reeves DS
    Arch Intern Med; 1982 Oct; 142(11):2023-32. PubMed ID: 6215009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity of enoxacin in vitro and in urine].
    Soussy CJ; Deforges L; Duval J
    Pathol Biol (Paris); 1987 May; 35(5):475-81. PubMed ID: 3302849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
    Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F
    Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
    Galante D; Esposito S; Barba D
    Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of enoxacin analogues with a variant at position 1.
    Nishimura Y; Minamida A; Matsumoto J
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1223-8. PubMed ID: 3165722
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
    Cullmann W; Stieglitz M; Baars B; Opferkuch W
    Chemotherapy; 1985; 31(1):19-28. PubMed ID: 3156025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
    Marklein G; Häfelein J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):40-53. PubMed ID: 6277101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro availability studies of enoxacin in presence of H2 receptor antagonists.
    Arayne MS; Sultana N; Haroon U; Hamza E
    Pak J Pharm Sci; 2007 Jul; 20(3):235-43. PubMed ID: 17545110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.
    Nakamura S; Minami A; Katae H; Inoue S; Yamagishi J; Takase Y; Shimizu M
    Antimicrob Agents Chemother; 1983 May; 23(5):641-8. PubMed ID: 6575721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pefloxacin activity against recent clinical isolates.
    Lembo M; Covelli B; Nani E; Lavitola A
    J Chemother; 1991 Jan; 3 Suppl 1():51-3. PubMed ID: 12041785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.